[ RECIPIENT ENTITY RECORD ]

ImmunoGen Inc.

VERIFIED NODE ID: 002036 · immunogen-inc
R TARGET NODE — CAPITAL RECIPIENT
ImmunoGen Inc.
Company United States
Recipient Type
Company
Primary Jurisdiction
United States
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name ImmunoGen Inc.
Entity Type Company
Jurisdiction United States
Recipient Intelligence Summary

ImmunoGen is a biotechnology company focused on developing antibody-drug conjugates for the treatment of cancer, providing targeted therapies for patients. Based in Massachusetts, the firm’s technology aims to destroy tumors while sparing healthy tissue. It was a primary destination for institutional healthcare capital through its strategic acquisition.

Capital Influx Log (Transactions)
Date Type Amount
23 May 2026 EQUITY $10.1B